NRXS
NRXS
AMEX · Health Care

Neuraxis Inc

$7.99
+0.59 (+7.97%)
As of Sep 29, 3:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
5.06M
Net Income
-11,055,650
Gross Margin
84.2%
Profit Margin
-218.6%
Rev Growth
+10.0%
D/E Ratio
0.04
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 84.2% 84.2% 30.5% 30.5%
Operating Margin -219.4% -197.4% 14.0% 11.2%
Profit Margin -218.6% -207.6% 12.4% 11.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.06M 4.60M 19.57M 23.82M
Gross Profit 4.26M 3.87M 5.97M 7.26M
Operating Income -11,095,618 -9,076,582 2.75M 2.67M
Net Income -11,055,650 -9,043,887 2.43M 2.81M
Gross Margin 84.2% 84.2% 30.5% 30.5%
Operating Margin -219.4% -197.4% 14.0% 11.2%
Profit Margin -218.6% -207.6% 12.4% 11.8%
Rev Growth +10.0% +10.0% +8.8% +17.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.03M 2.03M 14.27M 14.18M
Total Equity 46.63M 46.63M 32.33M 35.28M
D/E Ratio 0.04 0.04 0.44 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -11,013,168 -9,509,643 3.28M 4.05M
Free Cash Flow — — 3.09M 3.19M